Developments in obesity treatment are being reported, with a focus on GLP-1 medicines. Some outlets are discussing the use and effects of existing GLP-1 weight-loss drugs, such as semaglutide and ozempic, while others are looking ahead to potential new treatments, including orforglipron, which is being studied in clinical trials. The World Health Organization has issued guidelines on the use of GLP-1 medicines for obesity treatment, indicating ongoing interest and research in this area.